GLP-1R, a core member of the GPCR family, is widely present on the surfaces of various cells in the human body.1,2 By specifically binding to the key hormone GLP-1, it regulates blood glucose levels and lipid metabolism.3,4 This receptor and its agonists hold significant therapeutic potential, reshaping the treatment approaches for multiple diseases, including diabetes, cardiovascular disorders, and neurodegenerative diseases .5,6,7 GLP-1 is a peptide produced by the cleavage of proglucagon, mainly synthesized in the intestinal mucosal L-cells, pancreatic islet -cells, and neurons in the nucleus of the solitary tract.3,4 GLP-1RAs mimic the action of endogenous GLP-1, activating GLP-1R, thereby enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and reducing food intake through central appetite suppression.8,9,10 These mechanisms make GLP-1RAs powerful tools for controlling blood glucose and improving metabolic syndrome
Decisions about combination protocols should be made individually with a qualified provider based on the specific injury and goals involved
In the study comparing Mounjaro to semaglutide (1 mg), Mounjaro lowered patient weight by an average of 17 pounds (5 mg), 21 pounds (10 mg), and 25 pounds (15 mg) versus 13 pounds with semaglutide
Call: Columbus 614-861-0967 Kenton 419-673-0595 London 740-845-5500 Martins Ferry 740-633-1100 Email: [email protected] Frequently Asked Questions If you also want to ask any questions, please contact us
Q: What happens if I can't tolerate semaglutide side effects
At times, there were supply shortages because Ozempic was prescribed "off-label" so often that it was no longer available for the true target group (namely diabetics)
